Factors such as your baseline metabolic rate, genetic makeup, underlying insulin resistance, hormonal imbalances, and starting weight all influence how strongly and quickly you respond to GLP-1 medications
The glucagon receptor component is the new piece, and it is what makes retatrutide a distinct research question rather than a semantic extension of the tirzepatide class
The researchers specifically noted this finding "could provide reassurance that a greater proportion of lean mass is not lost with retatrutide despite the overall increased weight loss." For a bodybuilder interpreting this data, the practical implication is clear
The medication is marketed by the brand names Zepbound and Mounjaro
saying they currently take the medications
The second dual GIP/GLP-1 receptor agonist, tirzepatide (previously known as LY3298176